There are 2789 resources available
LBA21 - Radioembolization with chemotherapy for colorectal liver metastases: A randomized, open-label, international, multicenter, phase III trial (EPOCH study)
Presenter: Mary Mulcahy
Session: Proffered Paper session - Gastrointestinal tumours, colorectal 2
Resources:
Abstract
Slides
Webcast
384O - Laparoscopic versus open hemihepatectomy: The ORANGE II PLUS multicenter randomized controlled trial
Presenter: Robert Fichtinger
Session: Proffered Paper session - Gastrointestinal tumours, colorectal 2
Resources:
Abstract
Slides
Webcast
LBA47 - Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO): Final results of phase III Atalante-1 randomised trial
Presenter: Benjamin Besse
Session: Proffered Paper session - NSCLC, metastatic 2
Resources:
Abstract
Slides
Webcast
1281O - Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB+) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C
Presenter: Rafal Dziadziuszko
Session: Proffered Paper session - NSCLC, metastatic 2
Resources:
Abstract
Slides
Webcast
LBA48 - DUBLIN-3 (BPI-2358-103): A global phase (Ph) III trial with the plinabulin/docetaxel (Plin/Doc) combination vs. Doc in 2nd/3rd Line NSCLC patients (pts) with EGFR-wild type (wt) progressing on a prior platinum-based regimen
Presenter: Trevor Feinstein
Session: Proffered Paper session - NSCLC, metastatic 2
Resources:
Abstract
Slides
Webcast
1191O - MRTX-500: Phase II trial of sitravatinib (sitra) + nivolumab (nivo) in patients (pts) with non-squamous (NSQ) non-small cell lung cancer (NSCLC) progressing on or after prior checkpoint inhibitor (CPI) therapy
Presenter: Ticiana Leal
Session: Proffered Paper session - NSCLC, metastatic 2
Resources:
Abstract
Slides
Webcast
1501O_PR - Long-term estimates of cancer incidence and mortality for the EU and EFTA countries according to different demographic scenarios
Presenter: Tadeusz Dyba
Session: Proffered Paper session - Public policy
Resources:
Abstract
Slides
Webcast
1502O - OncoYoung program: A multidisciplinary program for young cancer patients
Presenter: Irit Ben-Aharon
Session: Proffered Paper session - Public policy
Resources:
Abstract
Slides
Webcast
1503O - Clinical and scientific impact of National Cancer Institute: Sponsored clinical trial network group treatment trials
Presenter: Joseph Unger
Session: Proffered Paper session - Public policy
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA48 & 1191O
Presenter: Maurice Pérol
Session: Proffered Paper session - NSCLC, metastatic 2
Resources:
Slides
Webcast